Nathalie Dubois-Stringfellow
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nathalie Dubois-Stringfellow
Sangamo Therapeutics, Inc reported in an 8-K filed August 9, 2022 that Nathalie Dubois-Stringfellow was appointed Senior Vice President, Head of Development, effective August 19, 2022. The proxy statement of Sangamo Therapeutics, Inc reports total compensation of $1,132,369 for Nathalie Dubois-Stringfellow in fiscal 2024, including a base salary of $453,600. Disclosed compensation is on record for 2 fiscal years. Nathalie Dubois-Stringfellow has spoken on 2 earnings calls across 1 company, most recently for Sangamo Therapeutics, Inc on May 14, 2026.
“Effective August 19, 2022, Nathalie Dubois-Stringfellow, Ph.D., currently serving as Senior Vice President, Product Development and Management, will assume the role of Senior Vice President, Head of Development of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Sangamo Therapeutics, Inc (SGMOQ)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sangamo Therapeutics, Inc
Other people whose current roles at this company are on record from its filings.
- Alexander D. Macrae CEO, Board Member
- Kathy Y. Yi CFO
- Nikunj Jain CFO, Chief Accounting Officer
- Sung H. Lee CFO
- D. Mark McClung COO
- Scott B. Willoughby General Counsel
- Alexander D. Macrae, M.B., Ch.B., Ph.D. Board Member
- Courtney Beers Board Member
- Courtney Beers, Ph.D. Board Member
- Courtney Beers, PhD. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Sangamo Therapeutics, Inc (SGMOQ) | Chief Development Officer | $453,600 | $1,132,369 |
| 2023 | Sangamo Therapeutics, Inc (SGMOQ) | Senior Vice President, Chief Development Officer | $453,600 | $1,027,105 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.